Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-000162-40-SE

Enrollment

120

Registered

2005-08-16

Start date

2005-09-06

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condylomata acuminata (genital warts)

Interventions

Product Name: Interferon alpha-2b Cream Product Code: IFNa-2b Pharmaceutical Form: Cream INN or Proposed INN: Interferon alpha-2b Other descriptive name: Interferon alfa-2b, [98530-12-2], Interferon a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical diagnosis of condylomata acuminata with HPV status confirmation Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Pregnant or lactating females

Design outcomes

Primary

Measure	Time frame
Main Objective: Efficacy;Secondary Objective: Safety ;Primary end point(s): Complete clearance of baseline warts	—

Countries

Germany, Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026